date:May 26, 2012
nted bioavailability, and they tested a strong hypothesis.
They also chose a target population [healthy seniors] where they were likely to see a result. The only downside to seniors is that they are hard to keep in the study and the study had a significant dropout of about 50% in both groups.
This study creates a nice set of evidence for other researchers to build on.
Study details
The Swedish researchers, led by Urban Alehagen, MD, PhD, investigated the vital relationship between the two su